Advertisement

Topics

UPDATE 1-Lundbeck says Alzheimer's drug fails in late-stage study

10:42 EDT 22 Sep 2016 | Reuters

Sept 22 (Reuters) - Danish drugmaker H Lundbeck A/S said its experimental Alzheimer's drug failed in a late-stage study, underscoring the challenges faced by drugmakers to tackle the debilitating disease.

Original Article: UPDATE 1-Lundbeck says Alzheimer's drug fails in late-stage study

NEXT ARTICLE

More From BioPortfolio on "UPDATE 1-Lundbeck says Alzheimer's drug fails in late-stage study"

Quick Search
Advertisement
 

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...